About tildrakizumab
Interleukin-23 inhibitor monoclonal antibody
Used for
- Moderate-to-severe plaque psoriasis in adults who may benefit from systemic treatment or phototherapy
Usual adult dose
100 mg under the skin at weeks 0 and 4, then every 12 weeks.
Common side effects
- Upper respiratory infections
- Injection-site reactions
- Diarrhea
Important warnings
- Avoid live vaccines during treatment.
- Screen for tuberculosis before starting; treat latent infection when indicated.
- Do not use during an active serious infection.
Pregnancy
Human pregnancy data are limited; use only when clinically necessary.
Breastfeeding
It is unknown whether tildrakizumab passes into breast milk; discuss potential risks.
Interactions
- Live vaccines may be unsafe during treatment.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.